Exact Mass: 486.200892

Exact Mass Matches: 486.200892

Found 25 metabolites which its exact mass value is equals to given mass value 486.200892, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide

N-(4-Cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy)acetamide

C26H26N6O4 (486.20154360000004)


MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].

   

Catharanthine tartrate

2,3-dihydroxybutanedioic acid;methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate

C21H24N2O2.C4H6O6 (486.200206)


   

Pauciflorine B

Pauciflorine B

C25H30N2O8 (486.200206)


   

Kopsidine A

Kopsidine A

C25H30N2O8 (486.200206)


   

Methyl-11,12-dimethoxychanofruticosinate

Methyl-11,12-dimethoxychanofruticosinate

C25H30ON2O7 (486.200206)


   

eleutherazine A

eleutherazine A

C25H30N2O8 (486.200206)


   

11-methoxykopsingine

11-methoxykopsingine

C25H30N2O8 (486.200206)


   

boletocrocin E

boletocrocin E

C25H30N2O8 (486.200206)


   

Catharanthine tartrate

2,3-dihydroxybutanedioic acid;methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate

C25H30N2O8 (486.200206)


   

O-Desmethylquinidine glucuronide

O-Desmethylquinidine glucuronide

C25H30N2O8 (486.200206)


   

O-Desmethylquinine glucuronide

O-Desmethylquinine glucuronide

C25H30N2O8 (486.200206)


   

Atrazine glutathione conjugate

Atrazine glutathione conjugate

C18H30N8O6S (486.200892)


   

MRS 1754

N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide

C26H26N6O4 (486.20154360000004)


MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].

   

LPA 20:6;O2

LPA 20:6;O2

C23H35O9P (486.20185900000007)


   

Catharanthine (Tartrate)

Catharanthine (Tartrate)

C25H30N2O8 (486.200206)


Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1]. Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1].

   

2-({15-[(1-carboxy-2-methylpropyl)-c-hydroxycarbonimidoyl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene}amino)butanedioic acid

2-({15-[(1-carboxy-2-methylpropyl)-c-hydroxycarbonimidoyl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene}amino)butanedioic acid

C25H30N2O8 (486.200206)


   

2,18-dimethyl (1s,9s,18s)-18-hydroxy-4,5-dimethoxy-21-oxo-2,12-diazapentacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸]henicosa-3(8),4,6,16(20)-tetraene-2,18-dicarboxylate

2,18-dimethyl (1s,9s,18s)-18-hydroxy-4,5-dimethoxy-21-oxo-2,12-diazapentacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸]henicosa-3(8),4,6,16(20)-tetraene-2,18-dicarboxylate

C25H30N2O8 (486.200206)


   

2,18-dimethyl (1s,9r,16r,17r,18r,21r)-17,18-dihydroxy-4,5-dimethoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3(8),4,6,14-tetraene-2,18-dicarboxylate

2,18-dimethyl (1s,9r,16r,17r,18r,21r)-17,18-dihydroxy-4,5-dimethoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3(8),4,6,14-tetraene-2,18-dicarboxylate

C25H30N2O8 (486.200206)


   

3-({4-[2,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propoxy]phenyl}methyl)-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

3-({4-[2,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propoxy]phenyl}methyl)-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C25H30N2O8 (486.200206)


   

(3s,8ar)-3-({4-[(1s,2r)-2,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propoxy]phenyl}methyl)-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3s,8ar)-3-({4-[(1s,2r)-2,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propoxy]phenyl}methyl)-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C25H30N2O8 (486.200206)


   

(2s)-2-{[(2e,4e,6e,8e,10e,12e,14e)-15-{[(1s)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]amino}butanedioic acid

(2s)-2-{[(2e,4e,6e,8e,10e,12e,14e)-15-{[(1s)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]amino}butanedioic acid

C25H30N2O8 (486.200206)


   

2,18-dimethyl 17,18-dihydroxy-4,5-dimethoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3(8),4,6,14-tetraene-2,18-dicarboxylate

2,18-dimethyl 17,18-dihydroxy-4,5-dimethoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3(8),4,6,14-tetraene-2,18-dicarboxylate

C25H30N2O8 (486.200206)


   

13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-15-hydroxy-11,20-dimethoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate

13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-15-hydroxy-11,20-dimethoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate

C25H30N2O8 (486.200206)


   

13,15-dimethyl (1s,2r,6r,14s,15r,18s,20s)-15-hydroxy-11,20-dimethoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate

13,15-dimethyl (1s,2r,6r,14s,15r,18s,20s)-15-hydroxy-11,20-dimethoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate

C25H30N2O8 (486.200206)


   

2,18-dimethyl 18-hydroxy-4,5-dimethoxy-21-oxo-2,12-diazapentacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸]henicosa-3(8),4,6,16(20)-tetraene-2,18-dicarboxylate

2,18-dimethyl 18-hydroxy-4,5-dimethoxy-21-oxo-2,12-diazapentacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸]henicosa-3(8),4,6,16(20)-tetraene-2,18-dicarboxylate

C25H30N2O8 (486.200206)